VEGFA and age-related macular degeneration: Although neovascular “wet” AMD currently is treated using anti-vascular endothelial growth factor (VEGF) intravitreal injections to prevent choroidal neovascularisation (CNV) (81, 82), early “dry” AMD and late-stage atrophic dry AMD are currently untreatable.